THMO (ThermoGenesis Holdings) Cyclically Adjusted Revenue per Share: $1,141.10 (As of Mar. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

THMO ThermoGenesis Holdings Inc THMO
16 GF Score
Price $0.00
View Full Analysis

What is ThermoGenesis Holdings Cyclically Adjusted Revenue per Share?

ThermoGenesis Holdings THMO 16 Cyclically Adjusted Revenue per Share is $1,141.10 as of Mar. 2024. GuruFocus rates THMO with a GF Score™ of 16/100.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

ThermoGenesis Holdings's adjusted revenue per share for the three months ended in Mar. 2024 was $0.680. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $1,141.10 for the trailing ten years ended in Mar. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2026-07-19), ThermoGenesis Holdings's current stock price is $0.0001. ThermoGenesis Holdings's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was $1,141.10. ThermoGenesis Holdings's Cyclically Adjusted PS Ratio of today is 0.00.


ThermoGenesis Holdings  (OTCPK:THMO) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

ThermoGenesis Holdings's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=0.0001/1141.10
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


ThermoGenesis Holdings Cyclically Adjusted Revenue per Share Related Terms


ThermoGenesis Holdings Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for ThermoGenesis Holdings's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ThermoGenesis Holdings Cyclically Adjusted Revenue per Share Chart

ThermoGenesis Holdings Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5,648.98 4,254.50 3,309.63 2,343.79 1,295.35

ThermoGenesis Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,066.61 1,818.18 1,594.74 1,295.35 1,141.10

THMO vs MSIU, MOTS, ABT: Cyclically Adjusted Revenue per Share Comparison

For the Medical Devices subindustry, ThermoGenesis Holdings's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ThermoGenesis Holdings Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ThermoGenesis Holdings's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where ThermoGenesis Holdings's Cyclically Adjusted PS Ratio falls into.


THMO
16GF Score
ThermoGenesis Holdings Inc THMO
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ThermoGenesis Holdings Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, ThermoGenesis Holdings's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.68/312.3320*312.3320
=0.680

Current CPI (Mar. 2024) = 312.3320.

ThermoGenesis Holdings Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 959.250 238.343 1,257.031
201409 913.750 238.031 1,198.976
201412 1,160.750 234.812 1,543.956
201503 1,010.500 236.119 1,336.663
201506 925.500 238.638 1,211.304
201509 564.600 237.945 741.107
201512 658.800 236.525 869.947
201603 472.000 238.132 619.071
201606 425.714 241.018 551.677
201609 289.769 241.428 374.870
201612 182.045 241.432 235.505
201703 147.818 243.801 189.369
201706 159.136 244.955 202.908
201709 139.500 246.819 176.527
201712 133.818 246.524 169.540
201803 77.792 249.554 97.361
201806 58.941 251.989 73.055
201809 63.531 252.439 78.604
201812 48.873 251.233 60.759
201903 53.855 254.202 66.170
201906 69.435 256.143 84.667
201909 62.431 256.759 75.944
201912 24.600 256.974 29.899
202003 34.783 258.115 42.089
202006 16.014 257.797 19.402
202009 15.805 260.280 18.966
202012 11.063 260.474 13.266
202103 5.972 264.877 7.042
202106 8.306 271.696 9.548
202109 11.917 274.310 13.569
202112 9.125 278.802 10.222
202203 9.247 287.504 10.046
202206 10.130 296.311 10.678
202209 3.043 296.808 3.202
202212 2.581 296.797 2.716
202303 2.058 301.836 2.130
202306 0.916 305.109 0.938
202309 0.876 307.789 0.889
202312 0.665 306.746 0.677
202403 0.680 312.332 0.680

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of $1,141.10 mean?
ThermoGenesis Holdings (THMO) has a Cyclically Adjusted Revenue per Share of $1,141.10 as of Mar. 2024. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on ThermoGenesis Holdings and its competitors.
Is ThermoGenesis Holdings' Cyclically Adjusted Revenue per Share too high?
ThermoGenesis Holdings' current Cyclically Adjusted Revenue per Share is $1,141.10. Overall, ThermoGenesis Holdings has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does ThermoGenesis Holdings' Cyclically Adjusted Revenue per Share compare to MSIU and MOTS?
ThermoGenesis Holdings' Cyclically Adjusted Revenue per Share of $1,141.10 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on ThermoGenesis Holdings and its competitors. ThermoGenesis Holdings's current Cyclically Adjusted Revenue per Share is $1,141.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ThermoGenesis Holdings stock overvalued right now?
ThermoGenesis Holdings (THMO) has a current Cyclically Adjusted Revenue per Share of $1,141.10. The current Cyclically Adjusted Revenue per Share is $1,141.10. ThermoGenesis Holdings' overall GF Score™ is 16/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For ThermoGenesis Holdings (THMO), the current Cyclically Adjusted Revenue per Share is $1,141.10 as of Mar. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ThermoGenesis Holdings Business Description

Address 2711 Citrus Road, Rancho Cordova, CA, USA, 95742
ThermoGenesis Holdings Inc develops, commercializes and markets a range of automated technologies for CAR-T and other cell-based therapies. The company markets a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally-closed CAR-TXpress platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market. It offers the AutoXpress and BioArchive platforms for automated clinical bio-banking, PXP platform for point-of-care cell-based therapies and CAR-TXpress platform for bio-manufacturing for immuno-oncology applications.
16GF Score

Get the complete analysis for THMO

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price